Oxford Nanopore to participate in September investor conferences

ONT

Oxford Nanopore Technologies plc (LON:ONT), the company delivering a new generation of molecular sensing technology based on nanopores, will be participating in the following investor conferences in September.

·      Morgan Stanley Global Healthcare Conference, New York

Format: Fireside chat and investor meetings

Date: Tuesday, 15 September

Francis Van Parys, Chief Executive Officer, and Nick Keher, Chief Financial Officer, will participate in an analyst led fireside chat at 10:45am EDT (3:45pm BST).

·      RBC Capital Markets Pharma Services & Life Science Tools Virtual Conference

Format: Fireside chat and investor meetings

Date: Tuesday, 22 September

Nick Keher, Chief Financial Officer, will participate in an analyst led fireside chat at 3:15pm BST (10:15am EDT).

A webcast of both fireside chats will be accessible through Oxford Nanopore’s Investor Relations website. The webcasts will be available for replay for at least 30 days after the event.

Share on:

Latest Company News

Oxford Nanopore to participate in September investor conferences

Oxford Nanopore will take part in the Morgan Stanley Global Healthcare Conference and RBC Capital Markets Pharma Services & Life Science Tools Virtual Conference in September, with fireside chats available via webcast.

Oxford Nanopore appoints David Miller as Chief Development and Product Officer

Oxford Nanopore Technologies has appointed David Miller as Chief Development and Product Officer and confirmed Conor McKechnie as Chief Marketing and Communications Officer. The new executive hires, both joining the leadership team this autumn, are intended to align product development, marketing and commercial execution as the company scales its differentiated technology platform.

Oxford Nanopore lifts gross margin and improves EBITDA in H1 2026

Oxford Nanopore reported higher first-half revenue, improved gross margin and updated its 2030 revenue and EBITDA margin targets.

Oxford Nanopore reports FY2025 revenue ahead of guidance

Oxford Nanopore Technologies expects to report full year 2025 revenue of approximately £223–£224 million, representing around 22% reported growth and 24% growth at constant currency, slightly ahead of guidance.

Oxford Nanopore Technologies to participate in January investor conferences

Oxford Nanopore Technologies will participate in the 44th Annual J.P. Morgan Healthcare Conference in San Francisco and the dbAccess UK & Ireland Conference in London during January.

    Search